FindTrial
Sign In

Sevoflurane improves lung ischemia-reperfusion injury by regulating autophagy

Sevoflurane improves lung ischemia-reperfusion injury by regulating autophagy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049203
Enrollment
Unknown
Registered
2021-07-25
Start date
2021-07-26
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung injury

Interventions

Experimental group:Inhalation of sevoflurane before pulmonary artery perfusion
Control group:Total intravenous anesthesia

Sponsors

Wuxi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who are planning to undergo lung transplantation.

Exclusion criteria

Exclusion criteria: History of narcotic drug abuse.

Design outcomes

Primary

MeasureTime frame
Lung function index;—

Countries

China

Contacts

Public ContactHuang Dongxiao

Wuxi People's Hospital

hdxss88@163.com+86 13665187308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026